The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Understanding the Legal Risks of BPC 157 and Other Unapproved Peptides Holt Law BPC 157: Experimental Peptide Creates Risk for Athletes